SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356090-23-000017
Filing Date
2023-11-09
Accepted
2023-11-09 17:08:34
Documents
95
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pgen-20230930.htm   iXBRL 10-Q 1370352
2 EX-31.1 pgen-20230930xexx311.htm EX-31.1 10379
3 EX-31.2 pgen-20230930xexx312.htm EX-31.2 10042
4 EX-32.1 pgen-20230930xexx321.htm EX-32.1 5809
5 EX-32.2 pgen-20230930xexx322.htm EX-32.2 5886
  Complete submission text file 0001356090-23-000017.txt   7667181

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pgen-20230930.xsd EX-101.SCH 53409
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pgen-20230930_cal.xml EX-101.CAL 94920
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pgen-20230930_def.xml EX-101.DEF 279437
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pgen-20230930_lab.xml EX-101.LAB 672503
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pgen-20230930_pre.xml EX-101.PRE 477415
89 EXTRACTED XBRL INSTANCE DOCUMENT pgen-20230930_htm.xml XML 1011309
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36042 | Film No.: 231393676
SIC: 2834 Pharmaceutical Preparations